Old Web
English
Sign In
Acemap
>
authorDetail
>
Stephen M. Sorensen
Stephen M. Sorensen
Aventis Pharma
Psychology
Neuroscience
Endocrinology
Internal medicine
Schizophrenia
5
Papers
49
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Effect of AMPA receptor modulators on hippocampal and cortical function
2000
European Journal of Pharmacology
Mark D. Black
Jill Wotanis
Donald E. Schilp
Susan E. Hanak
Stephen M. Sorensen
Joseph Wettstein
Show All
Source
Cite
Save
Citations (13)
Animal Models of Negative Symptoms: M100907 Antagonizes PCP-Induced Immobility in a Forced Swim Test in Mice
1999
Neuropsychopharmacology
Roy Corbett
Lily Zhou
Stephen M. Sorensen
Cesare Mondadori
Show All
Source
Cite
Save
Citations (35)
Striatal dopamine D2, cortical 5HT2A and striatal neurotensin receptor levels in neonatal hippocampal lesioned (NHL) male and female rats
1997
Schizophrenia Research
Mark D. Black
Janice M. Hitchcock
Paul van Giersbergen
Stephen M. Sorensen
Show All
Source
Cite
Save
Citations (0)
The receptor binding profile of MDL 100,907
1996
Schizophrenia Research
P.L.M. van Giersbergen
Bruce M. Baron
Jack Elands
Michael P. Johnson
Stephen M. Sorensen
Show All
Source
Cite
Save
Citations (1)
Preclinical profile of MDL 100 907, a potent and selective 5-HT2A antagonist in development for schizophrenia
1996
Schizophrenia Research
Stephen M. Sorensen
Albert A. Carr
P.L.M. van Giersbergen
Janice M. Hitchcock
John H. Kehne
Christopher J. Schmidt
Show All
Source
Cite
Save
Citations (0)
1